SENSEX NIFTY

Pharma

Oct 22, 2014 at 19:05 | Source: Moneycontrol.com
Chemo-Pharma Laboratories has reported a sales total income from operations of Rs 0.11 crore and a net profit of Rs 0.07 crore for the quarter ended Sep '14
Oct 22, 2014 at 18:20 | Source: CNBC-TV18
In an interview to CNBC-TV18, Ravi Menon, AVP - IT, Centrum Broking, Vibhor Singhal, IT Analyst, Phillip Capital and Sarabjit Kaur Nangra, VP - Research Pharma, Angel Broking spoke about Wipros financial performance in the quarter gone by and the road ahead.
Oct 22, 2014 at 17:33 | Source: CNBC-TV18
The Nifty is up more than 25 percent, the Bank Nifty has gained more than 40 percent. The midcap and small cap space has outperformed key indices.
Oct 22, 2014 at 16:28 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying Aurobindo Pharma on dips.
Oct 22, 2014 at 16:24 | Source: CNBC-TV18
P Phani Sekhar, Fund Manager, PMS at Angel Broking is of the view that one may prefer Divis Labs, Wipro, Hindustan Media Ventures, Indiabulls Housing Finance and LIC Housing Finance.
Oct 22, 2014 at 15:27 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying Aurobindo Pharma, Tata Chemicals and Reliance Industries.
Oct 22, 2014 at 10:34 | Source: Moneycontrol.com
Equity and Debt Mutual Funds surge as market rallied for the third consecutive session on Tuesday with the benchmark Nifty closing above the 7900 level supported by banks, metals, auto and capital goods stocks.
Oct 22, 2014 at 09:36 | Source: CNBC-TV18
Sukhani prefers to stay with Nifty stocks like IT, pharma, FMCG and capital group, L&T, BHEL, everything except the Bank Nifty for the day.
Oct 21, 2014 at 13:09 | Source: CNBC-TV18
Manav Chopra of Nirmal Bang recommends buying Aurobindo Pharma for a target price of Rs 985 and Rural Electrification Corporation for a target price of Rs 300.
Oct 21, 2014 at 13:08 | Source: CNBC-TV18
Oswal also likes defensive sectors like technology although the growth is slightly concerned but technology, FMCG and Pharma as most of the quality stocks would be there.
Messages on Pharma »

subs74

Silver Member

3 Followers

Biocon  

Namo baba, at the end of the day its about fundamentals as also whether stock is in strong hands. pls look at other midcap pharma stocks like cadila, zydus,ipca. They have all gone up even on such a day despite having run up already which means they are in strong hands who dont allow the stocks

4.54 PM Jul 8th

abhishek_co
ssipore

New Member

1 Followers

Dishman Pharma  

Hold Dishman Pharma Targe Price 205

4.48 PM Jul 8th

subs74

Silver Member

3 Followers

Biocon  

I can understand a minor correction due to market sentiment but a 7% fall in a pharma stock like Biocon on the day of railway budget with which it has no correlation is strange. Either the correction is silly or the upmove itself in Biocon was not based on any fundamentals.

4.33 PM Jul 8th

Ajanta Pharma  

After AGM the share price will shoot up towards benefits to all investers - My target for Ajanta Pharma is Rs 2500 for the long term with a stoploss of Rs 1499

4.30 PM Jul 8th

Ravi_jangra

New Member

0 Follower

Alembic Pharma  

Salute to alembic pharma....All stocks down but alembic not....Guys today see alembic strong unbreakable resistance on 300/-.This is righttime to entre now or never...Save me today from huge lose

4.19 PM Jul 8th

jagoinvesto
r

Platinum Member

115 Followers

Morepen Lab  

morepen to buy sun pharma

4.15 PM Jul 8th

JPInvestor

New Member

0 Follower

SMS Pharma  

my view is that the equity base of SMS Pharma is very small and already having good profit. hence it can easily cross the above figures.

3.55 PM Jul 8th

subs74

Silver Member

3 Followers

Biocon  

How does budget affect pharma stocks like biocon?

3.47 PM Jul 8th

shmarketgen
ius

Platinum Member

522 Followers

Tech Mahindra  

suggest,that you try & find a small/mid- cap Pharma/IT/Auto Ancillary company or a consumer play.These stories are huuuge in size & will pay rich dividends.

3.47 PM Jul 8th

countryman

Platinum Member

560 Followers

Granules India  

For solving the problem of CAD, Re cannot go down so much to probably 53 levels which will hurt the exporters. I understand that RBI will control Re between 58 to 61 level so that exporters will get benefitted. Company has expanded their facilities, bought Auctus Pharma and this year Auctus

3.36 PM Jul 8th

News across the web »
Oct 21, 2014 at 02:30 | Source: FirstPost
Oct 20, 2014 at 00:00 | Source: NDTV Profit
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.